Amitriptyline relieves diabetic neuropathy pain in patients with normalor depressed mood

Neurology

Volumn 37, Issue 4, 1987, Pages 589-596

  Max, M B ^a   Culnane, M ^a,b   Schafer, S C ^a,b   Gracely, R H ^a   Walther, D J ^a   Smoller, B ^a   Dubner, R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZATROPINE MESILATE; DIAZEPAM;

ANALGESIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG EFFICACY; DRUG THERAPY; ENDOCRINE SYSTEM; HUMAN; ORAL DRUG ADMINISTRATION; PAIN; PERIPHERAL NERVOUS SYSTEM; PHARMACOKINETICS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; THERAPY;

ADULT; AGED; AMITRIPTYLINE; DEPRESSION; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; RANDOM ALLOCATION;

EID: 0023155057     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.37.4.589     Document Type: Article

References (63)

1. Maciewicz R, Bouckoms A, Martin JB. Drug therapy of neuropathic pain. Clin J Pain 1985;1:39-49.
2. Rosenblatt RM, Reich J, Dehring D. Tricyclic antidepressants in treatment of depression and chronic pain: analysis of the supporting evidence. Anesth Analg 1984;63:1025-1032.
3. Feinmann C. Pain relief by antidepressants: possible modes of action. Pain 1985;23:1-8.
4. France RD, Houpt JL, Ellinwood EH. Therapeutic effects of antidepressants in chronic pain. Gen Hosp Psychiatry 1984;6:55-63.
5. Turkington RW. Depression masquerading as diabetic neuropathy. JAMA 1980;243:1147-1150.
6. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-1730.
7. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-673.
8. Langohr HD, Stohr M, Petruch F. An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies. Eur Neurol 1982;21:309-317.
9. Hallett M, Tandon D, Berardelli A. Treatment of peripheral neuropathies. J Neurol Neurosurg Psychiatry 1985;48:1193-1207.
10. Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol 1984;15:2-12.
11. Thomas PK, Eliasson SG. Diabetic neuropathy. In: Dyck RJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, vol 2, 2nd ed. Philadelphia: W B Saunders Co, 1984:1773-1810.
12. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983;46:491-499.
13. Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy: a 4-year study. Postgrad Med J 1983;59:556-559.
14. Mayne N. The short-term prognosis in diabetic neuropathy. Diabetes 1968;17:270-273.
15. Kikta DG, Breuer AC, Wilbourn AJ. Thoracic root pain in diabetes: the spectrum of clinical and electromyographic findings. Ann Neurol 1982;11:80-85.
16. Watkins PJ. Pain and diabetic neuropathy. Br Med J 1984;288:168-169.
17. Editorial. Pain perception in diabetic neuropathy. Lancet 1985;1:83-84.
18. Gracely RH, McGrath P, Dubner R. Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 1979;203:1261-1263.
19. Spitzer RL, Andreasen N, Arnstein RL, et al. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, DC: American Psychiatric Association, 1980:205-224.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-61.
21. McNair DM, Lorr M, Doppleman LF. Profile of mood states. San Diego: Educational and Industrial Testing Service, 1971.
22. Lubin B. Depression adjective checklists: manual, 2nd ed. San Diego: Educational and Industrial Testing Service, 1981.
23. Christenfeld R, Lubin B, Satin M. Concurrent validity of the depression adjective checklist in a normal population. Am J Psychiatry 1978;135:582-584.
24. Thoma JJ, Bondo PB, Kozak CM. Tricyclic antidepressants in serum by a clin-elut column extraction in high-pressure liquid chromatographic analysis. Ther Drug Monit 1979;1:335-338.
25. Gracely RH, McGrath PA, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain 1978;5:5-18.
26. Gracely RH, McGrath PA, Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 1978;5:19-29.
27. Gracely RH, Dubner R. Pain assessment in humans: a reply to Hall. Pain 1981;11:109-120.
28. Gracely RH, Dubner R, McGrath PA. Fentanyl reduces the intensity of painful tooth pulp sensations: controlling for detection of active drugs. Anesth Analg 1982;61:751-755.
29. Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol Bull 1985;97:18-34.
30. Blumer D, Heilbronn M. Chronic pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982;170:381-393.
31. Turk DC, Salovey P. ‘Chronic pain as a variant of depressive disease’: a critical reappraisal. J Nerv Mental Dis 1984;172:398-407.
32. France RD, Krishnan KRR, Houpt JL, Maltbie AA. Differentiation of depression from chronic pain with the dexamethasone suppression test and DSM-III. Am J Psychiatry 1984;141:1577-1579.
33. Kramlinger KG, Swanson DW, Maruta T. Are patients with chronic pain depressed? Am J Psychiatry 1983;140:747-749.
34. Murphy DL, Siever LJ, Insel TR. Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Prog Neuropsychopharmacol Biol Psychiatry 1985;9:3-13.
35. Hameroff SR, Cork RC, Scherer K, et al. Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry 1982;43:22-27.
36. Hameroff SR, Cork RC, Weiss J, Crago BR, Davis TP. Doxepin effects on chronic pain and depression: a controlled study. In: Fields HL, Dubner R, Cervero F, eds. Advances in pain research and therapy, vol 9. New York: Raven Press, 1985:761-772.
37. Watson CPN. Therapeutic window for amitriptyline analgesia. Can Med Assoc J 1984;130:105-106.
38. Lasagna L, Laties VG, Dohan JL. Further studies on the ‘pharmacology’ of placebo administration. J Clin Invest 1958;37:533-537.
39. Davis JM. Antidepressant drugs. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry, 4th ed. Baltimore: Williams & Wilkins, 1985:1513-1537.
40. Spiegel K, Kalb R, Pasternak GW. Analgesic activity of tricyclic antidepressants. Ann Neurol 1983;13:462-465.
41. Botney M, Fields HL. Amit riptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983;13:160-164.
42. Hammond DL. Pharmacology of central pain-modulating networks (biogenic amines and nonopioid analgesics). In: Fields HL, Dubner R, Cervero F, eds. Advances in pain research and therapy, vol 9. New York: Raven Press, 1985:499-511.
43. Dubner R, Bennett GJ. Spinal and trigeminal mechanisms of nociception. Ann Rev Neurosci 1983;6:381-418.
44. Roberts MHT. 5-Hydroxytryptamine and antinociception. Neuropharmacology 1984;23:1529-1536.
45. Peschanski M, Besson J-M. Diencephalic connections of the raphe nuclei of the rat brainstem: an anatomical study with reference to the somatosensory system. J Comp Neurol 1984;224:509-534.
46. Anderson E, Dafny N. An ascending serotonergic pain modulation pathway from the dorsal raphe nucleus to the parafascicularis nucleus of the thalamus. Brain Res 1983;269:57-67.
47. Schulz P, Dick P, Blaschke TF, Hollister L. Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pharmacokinetics 1985;10:257-268.
48. Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1981;38:1160-1180.
49. Charney DS, Heninger GR, Sternberg DE. Serotonin function and mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1984;41:359-365.
50. Willner P. Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacology (Berlin) 1985;85:387-404.
51. Snyder SH, Peroutka SJ. Antidepressants and neurotransmitter receptors. In: Post RM, Ballenger JC, eds. Neurobiology of mood disorders. Baltimore: Williams & Wilkins, 1984:686-697.
52. Tyrer P, Marsden C. New antidepressant drugs: is there anything new they tell us about depression? Trends in Neurosciences 1985;8:427-431.
53. Racagni G, Brunello N. Transsynaptic mechanisms in the action of antidepressant drugs. Trends in Pharmacol Sci 1984;5:527-531.
54. Clifford DB, Rutherford JL, Hicks FG, Zorumski CF. Acute effects of antidepressants on hippocampal seizures. Ann Neurol 1985;18:692-697.
55. Devor M. Nerve pathophysiology and mechanisms of pain in causalgia. J Auton Nerv Syst 1983;7:371-384.
56. Burchiel KJ, Russell LC, Lee RP, Sima AAF. Spontaneous activity of primary afferent neurons in diabetic bbzWistar rats: a possible mechanism of diabetic neuropathic pain. Diabetes 1985;34:1210-1213.
57. Gomez-Perez FJ, Rull JA, Dies H, Rodriguez-Rivera JG, Gonzalez-Barranco J, Lozano-Castaneda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study. Pain 1985;23:395-400.
58. Taub A. Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurg 1973;39:235-239.
59. Davis JL, Lewis SB, Gerich JE, Kaplan RA, Schultz TA, Wallin JD. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. JAMA 1977;238:2291-2292.
60. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 1982;39:473-481.
61. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985;23:387-394.
62. Hall H, Ogren S-O. Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 1981;70:393-407.
63. Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharm Exp Ther 1984;230:94-99.